BTRC and colorectal cancer: The increased expression and half-life of c-Myc protein can activate the β-TrCP/c-Myc/HK2 pathway, enhance glycolysis in colorectal cancer, significantly increase intracellular lactate, and promote the progression of colorectal cancer [66].